Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Acorn Capital Advisors, Llc
Form 13F · Q2 2026

Acorn Capital Advisors, Llc

CIK 2054410Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$366M
Reported book value
20
Positions
7
Quarters on record
Top 50
Positions

Acorn Capital Advisors, Llc — holdings

Top 20 positions of 20, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CGON Cg Oncology Inc1.1M+0.1%$80M21.9%
2URGN Urogen Pharma Ltd1.7M+0.0%$62M16.8%
3TRVI Trevi Therapeutics Inc2.1M+0.0%$40M10.9%
4CADL Candel Therapeutics Inc3.5M+0.0%$36M9.8%
5PBYI Puma Biotechnology Inc4.1M+0.0%$34M9.1%
6JBIO Jade Biosciences Inc986,760+25.4%$22M6.0%
7BCAX Bicara Therapeutics Inc643,381−0.0%$19M5.2%
8KPTIQ Karyopharm Therapeutics Inc1.5M+427.4%$15M4.0%
9OKUR Onkure Therapeutics Inc2.8M+0.0%$13M3.5%
10CYBIN INC Cybin Inc1.5M+0.0%$10M2.8%
11TARA Protara Therapeutics Inc1.8M+0.0%$7M1.8%
12AURA Aura Biosciences Inc929,077+56.0%$7M1.8%
13LONA Leonabio Inc634,539+0.0%$6M1.6%
14VSTM Verastem Inc1.5M+0.0%$6M1.5%
15WHWK Whitehawk Therapeutics Inc1.1M+0.0%$5M1.4%
16QTTB Q32 Bio Inc216,171−31.4%$3M0.8%
17ENGN Engene Therapeutics Inc1.3M—$2M0.6%
18JSPR Jasper Therapeutics Inc1.4M+1.9%$604,0270.2%
19BCAB Bioatla Inc108,126−98.0%$447,6450.1%
20VYNE THERAPEUTICS INC Vyne Therapeutics Inc1,425+0.0%$9260.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.